Aurobindo Pharma INR1 (NSE:AUROPHARMA) Price Target Increased by 26.48% to 869.61

The average one-year price target for Aurobindo Pharma INR1 (NSE:AUROPHARMA) has been revised to 869.61 / share. This is an increase of 26.48% from the prior estimate of 687.53 dated August 1, 2023. The price target is an average of many targets provided by analysts. The latestThe average one-year price target for Aurobindo Pharma INR1 (NSE:AUROPHARMA) has been revised to 869.61 / share. This is an increase of 26.48% from the prior estimate of 687.53 dated August 1, 2023. The price target is an average of many targets provided by analysts. The latest 

​ 

Leave a Reply

Your email address will not be published. Required fields are marked *

Search this website